(Q84564479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

7 February 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Molly Dayan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Heidy Zinger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Edna Mozes

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

16 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

34-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19756988%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10875-009-9326-4

7 February 2020

exact match

0 references

cites work

The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosus

1 reference

12 December 2020

T- and B-cell abnormalities in systemic lupus erythematosus

1 reference

12 December 2020

Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets

1 reference

12 December 2020

The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells

1 reference

12 December 2020

Phenotypic characterization of porcine IFN-gamma-producing lymphocytes by flow cytometry.

1 reference

12 December 2020

Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression.

1 reference

12 December 2020

Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action

1 reference

12 December 2020

Regulatory T cells and autoimmune disease

1 reference

12 December 2020

Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.

1 reference

12 December 2020

Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppression

1 reference

12 December 2020

Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA.

1 reference

12 December 2020

Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody

1 reference

12 December 2020

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

12 December 2020

Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation

1 reference

12 December 2020

Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosus

1 reference

12 December 2020

Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus

1 reference

12 December 2020

Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients

1 reference

12 December 2020

A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta

1 reference

12 December 2020

Tumour necrosis factor and other cytokines in murine lupus

1 reference

12 December 2020

The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications

1 reference

12 December 2020

Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.

1 reference

12 December 2020

Bcl-2 leads to expression of anti-DNA B cells but no nephritis: a model for a clinical subset

1 reference

12 December 2020

Crossing the bridge: large animal models in translational transplantation research

1 reference

12 December 2020

Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease

1 reference

12 December 2020

Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse.

1 reference

12 December 2020

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype

1 reference

12 December 2020

The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment

1 reference

12 December 2020

The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients.

1 reference

12 December 2020

The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse model.

1 reference

12 December 2020

A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.

1 reference

12 December 2020

Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide

1 reference

12 December 2020

Apoptosis in systemic lupus erythematosus

1 reference

12 December 2020

B cell apoptosis accelerates the onset of murine lupus

1 reference

12 December 2020

Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosis

1 reference

12 December 2020

A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation

1 reference

12 December 2020

Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) p

1 reference

12 December 2020

Pathogenesis of systemic lupus erythematosus

1 reference

12 December 2020

Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK

1 reference

12 December 2020

The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients

1 reference

12 December 2020

Cutting edge: amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-(beta-o-methyl)-fluoromethylketone

1 reference

12 December 2020

The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations

1 reference

12 December 2020

Key autoantigens in SLE.

1 reference

12 December 2020

The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus

1 reference

12 December 2020

The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models

1 reference

12 December 2020

Regulatory T cells in systemic lupus erythematosus: past, present and future

1 reference

12 December 2020

B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus

1 reference

12 December 2020

T-helper cells from naive to committed.

1 reference

12 December 2020

Cytokines and systemic lupus erythematosus

1 reference

12 December 2020

Modulation of autoreactive responses of peripheral blood lymphocytes of patients with systemic lupus erythematosus by peptides based on human and murine anti-DNA autoantibodies

1 reference

12 December 2020

Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells

1 reference

12 December 2020